¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѳúÀüÁõÇÐȸ 24rd KOREAN EPILEPSY CONGRESS : 2019-06-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѳúÀüÁõÇÐȸ 24rd KOREAN EPILEPSY CONGRESS : 2019-06-14
±³À°ÀÏÀÚ : 2019-06-14
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ¹éµÎȦ  
±³À°ÁÖÁ¦ : 24rd KOREAN EPILEPSY CONGRESS
ÁÖÃÖ±â°ü : ´ëÇѳúÀüÁõÇÐȸ
´ã´çÀÚ : ´ëÇѳúÀüÁõÇÐȸ
¿¬¶ôó : 02-362-9662  
À̸ÞÀÏ : epilepsy@kes.or.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú, Á¤½Å°Ç°­ÀÇÇаú, ½Å°æ¿Ü°ú, ½Å°æ°úÀÇ»çÇÐ, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 180,000¿ø      
ºñ°í [»çÀüµî·Ï] Àü¹®ÀÇ(Á¤È¸¿ø ¹× Á¾½Åȸ¿ø) : 100,000¿ø ÁØȸ¿ø(Àü°øÀÇ) : 60,000¿ø ºñȸ¿ø : 180,000¿ø ±â»ç.°£È£»ç.¿¬±¸¿ø : 30,000¿ø ±â¾÷ȸ¿ø : ¹«·á  [ÇöÀåµî·Ï] Àü¹®ÀÇ(Á¤È¸¿ø ¹× Á¾½Åȸ¿ø) : 120,000¿ø ÁØȸ¿ø(Àü°øÀÇ) : 80,000¿ø ºñȸ¿ø : 200,000¿ø ±â»ç.°£È£»ç.¿¬±¸¿ø : 50,000¿ø ±â¾÷ȸ¿ø : ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 06-14 GB A+B(@5F, Baekdu) 09:00~09:10 Opening Ceremony  () 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 09:10~09:40 From molecules to medicines: the dawn of targeted therapies for genetic epilepsies  °­ÈÆö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 09:40~10:10 Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications  Stéphanie Baulac(France) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 10:10~10:40 New therapeutic technologies for epilepsy surgery: focused ultrasound, laser therapy, sEEG, RF ablation and others  Benjamin Kennedy(USA) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 10:40~11:10 Machine learning and artificial Intelligence: Is the future already here?  Á¤±â¿µ(¼­¿ïÀÇ´ë) 
Åä·Ð 06-14 GB A+B(@5F, Baekdu) 11:10~11:20 Discussion  () 
È޽Ġ06-14 GB A+B(@5F, Baekdu) 11:20~11:30 Coffee Break  () 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 11:30~11:55 Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings  ±èÁöÇö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 11:55~12:20 Efficacy of lacosamide in drug-resistant epilepsy and refractory status epilepticus: A systematic review  ±èµ¿¿í(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 12:20~12:45 Other new antiepileptic drugs: brivaracetam, esclicarbazepine, cenobamate, etc.  Steve Chung(USA) 
Åä·Ð 06-14 GB A+B(@5F, Baekdu) 12:45~12:50 Discussion  () 
È޽Ġ06-14 GB A+B(@5F, Baekdu) 12:50~13:00 Break  () 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 13:00~14:00 Oral Presentation 1  () 
È޽Ġ06-14 GB A+B(@5F, Baekdu) 14:00~14:10 Coffee Break  () 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 14:10~14:30 Epileptic seizure prediction using big data and deep learning  È²Èñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 14:30~14:50 AI in brain imaging  ±è°ÇÈñ(¼­¿ï´ë °ø°ú´ëÇÐ) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 14:50~15:10 Dr. Answer project: AI EEG project by Korea government  ±è±âÁß(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 15:10~15:30 EEG Network: Big data analysis perspectives  ±èÇå¹Î(¼­¿ïÀÇ´ë) 
È޽Ġ06-14 GB A+B(@5F, Baekdu) 15:30~15:40 Break  () 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 15:40~16:05 General principle of localization and surgery for MRI-negative epilepsies  ÀÌ»ó°Ç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 16:05~16:30 Deep learning for medical image analysis: computer-aided detection of focal cortical dysplasia  Á¶±ÔÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 16:30~16:55 Electric source imaging in MRI-negative epilepsy  ±è´ë¿µ(Ãæ³²°ø´ë) 
Åä·Ð 06-14 GB A+B(@5F, Baekdu) 16:55~17:00 Discussion  () 
È޽Ġ06-14 GB A+B(@5F, Baekdu) 17:00~17:10 Coffee Break  () 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 17:10~17:30 New classifications of seizures and epilepsy  ±è¼¼À±(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 17:30~17:50 Clinical feature and drug choice of new onset epilepsy in children  ±è½ÅÇý(¸íÁöº´¿ø) 
±³À°½Ã°£ 06-14 GB A+B(@5F, Baekdu) 17:50~18:10 Clinical feature and drug choice of new onset epilepsy in adult  ¼±¿ìÁØ»ó(¼øõÇâÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѳúÀüÁõÇÐȸ 24rd KOREAN EPILEPSY CONGRESS : 2019-06-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ¿¹¹æÀÇÇÐȸ Á¦4±â Áö¿ª»çȸ °øÁߺ¸°Ç ÃÖ°í¸®´õ°úÁ¤: °ø°øÀÇ·á Æз¯´ÙÀÓÀÇ Àüȯ : 2019-06-15
´ÙÀ½±Û ¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø Á¦26Â÷ ´ëÇÑENDOUROLOGYÇÐȸ Çмú´ëȸ ¹× ¿öÅ©¼ó : 2019-06-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 25 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 26 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 31 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 29 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 26 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 19 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 7 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 14 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 5 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 17 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 10 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 19 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 12 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷